Article
Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.
Journal of medicinal chemistry - 26 Nov 2009
Jones Philip, Altamura Sergio, Boueres Julia, Ferrigno Federica, Fonsi Massimiliano, Giomini Claudia, Lamartina Stefania, Monteagudo Edith, Ontoria Jesus M, Orsale Maria Vittoria, Palumbi Maria Cecilia, Pesci Silvia, Roscilli Giuseppe, Scarpelli Rita, Schultz-Fademrecht Carsten, Toniatti Carlo, Rowley Michael
Abstract excerpt
We disclose the development of a novel series of 2-phenyl-2H-indazole-7-carboxamides as poly(ADP-ribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to improve enzyme and cellular activity, and the resulting PARP inhibitors display antiproliferation activities against BRCA-1 and BRCA-2 deficient cancer cells, with high selectivity over BRCA proficient cells. Extrahepatic oxidation by CYP450 1A1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
